000			02685nas a22001817a 4500
003			OSt
005			20230511124729.0
006			m|||||r|||| 00| 0
007			ta
008			171219t2006 sp ||||| |||| 00| 0 spa |
022			_a0160-6689
040			_cSalus Infirmorum
245	0		_aEstimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey / _cValerie S. L. Williams ; David S. Baldwin, D.M. ; Susan L. Hogue, Pharm.D. ; Sheri E. Fehnel ; Kelly A. Hollis ; and Heather M. Edin
504			_aBibliografía: p.209-210
520	8		_aObjective: Sexual dysfunction is a common side effect of antidepressant treatment, but recog-nition of the problem is variable. The aim of this study was to estimate the prevalence and impact of sexual dysfunction during antidepressant treat-ment in 2 European countries. Method: A cross-sectional survey of 502 adults in France and the United Kingdom. All participants were diagnosed with depression and taking a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), starting within the previous 3 months. Information was gathered about other medications and conditions known to impair sexual functioning, recent changes in sexual functioning, and the impact of any changes. The Medical Outcomes Study 12-Item Short-Form Health Survey and the Arizona Sexual Experience Scale were administered to measure health status and sexual functioning. Data were collected from June to July of 2002. Results: Applying a prevalence estimate algo-rithm, 26.6% of the French sample and 39.2% of the U.K. sample were classified as having antidepressant-induced sexual dysfunction; 34.2% of men and 32.5% of women were classified with antidepressant-induced sexual dysfunction. There was no clear pattern of antidepressant-induced sexual dysfunction related to specific antidepres-sants. Patients with antidepressant-induced sexual dysfunction reported that changes in sexual functioning negatively affected their self-esteem, mood, and relationships with sexual partners. 23.8% of the French sample and 25.2% of the U.K. sample reported that they perceived that their partner was dissatisfied with their sex life. Conclusion: The prevalence of antidepressant-induced sexual dysfunction in this study is similar to previous estimates reported in the literature. The impact of antidepressant-induced sexual dysfunction is substantial and negatively affects quality of life, self-esteem, mood, and relationships with sexual partners.
773			_g-- 2006 v. 67, n 2, p.204-210 _tJournal of Clinical Psychiatry
942			_2udc _cARTÍCULO
999			_c15061 _d15061